Lifecare (Norway) Performance
| LIFE Stock | NOK 14.50 0.35 2.36% |
The company secures a Beta (Market Risk) of 1.87, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Lifecare will likely underperform. At this point, Lifecare AS has a negative expected return of -0.51%. Please make sure to verify Lifecare's standard deviation, total risk alpha, maximum drawdown, as well as the relationship between the jensen alpha and treynor ratio , to decide if Lifecare AS performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Lifecare AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's essential indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors. ...more
| Begin Period Cash Flow | 11.5 M | |
| Total Cashflows From Investing Activities | -6.9 M |
Lifecare |
Lifecare Relative Risk vs. Return Landscape
If you would invest 2,181 in Lifecare AS on September 2, 2024 and sell it today you would lose (731.00) from holding Lifecare AS or give up 33.52% of portfolio value over 90 days. Lifecare AS is generating negative expected returns and assumes 4.6937% volatility on return distribution over the 90 days horizon. Simply put, 41% of stocks are less volatile than Lifecare, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Lifecare Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Lifecare's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Lifecare AS, and traders can use it to determine the average amount a Lifecare's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1081
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | LIFE |
Estimated Market Risk
| 4.69 actual daily | 41 59% of assets are more volatile |
Expected Return
| -0.51 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.11 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Lifecare is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Lifecare by adding Lifecare to a well-diversified portfolio.
Lifecare Fundamentals Growth
Lifecare Stock prices reflect investors' perceptions of the future prospects and financial health of Lifecare, and Lifecare fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Lifecare Stock performance.
| Return On Equity | -0.96 | |||
| Return On Asset | -0.47 | |||
| Profit Margin | (0.77) % | |||
| Operating Margin | (0.77) % | |||
| Current Valuation | 215.17 M | |||
| Shares Outstanding | 117.87 M | |||
| Price To Book | 11.93 X | |||
| Price To Sales | 13.15 X | |||
| EBITDA | (15.38 M) | |||
| Cash And Equivalents | 11.48 M | |||
| Cash Per Share | 0.14 X | |||
| Total Debt | 2.7 M | |||
| Book Value Per Share | 0.25 X | |||
| Cash Flow From Operations | (13.77 M) | |||
| Earnings Per Share | (0.16) X | |||
| Total Asset | 32.22 M | |||
About Lifecare Performance
By examining Lifecare's fundamental ratios, stakeholders can obtain critical insights into Lifecare's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Lifecare is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Lifecare AS engages in the research and development of medical sensors for health monitoring in Norway. The company was founded in 2006 and is headquartered in Bergen, Norway. LIFECARE is traded on Oslo Stock Exchange in Norway.Things to note about Lifecare AS performance evaluation
Checking the ongoing alerts about Lifecare for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Lifecare AS help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Lifecare AS generated a negative expected return over the last 90 days | |
| Lifecare AS has high historical volatility and very poor performance | |
| Net Loss for the year was (15.88 M) with profit before overhead, payroll, taxes, and interest of 1.6 M. | |
| Lifecare AS has accumulated about 11.48 M in cash with (13.77 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.14. | |
| Roughly 53.0% of the company outstanding shares are owned by corporate insiders |
- Analyzing Lifecare's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Lifecare's stock is overvalued or undervalued compared to its peers.
- Examining Lifecare's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Lifecare's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Lifecare's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Lifecare's stock. These opinions can provide insight into Lifecare's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Lifecare Stock
Lifecare financial ratios help investors to determine whether Lifecare Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Lifecare with respect to the benefits of owning Lifecare security.